Date published: 2026-6-8

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ang-2 Inhibitors

Common Ang-2 Inhibitors include, but are not limited to LY-333,531 Hydrochloride CAS 169939-93-9, TG101348 CAS 936091-26-8, Sunitinib, Free Base CAS 557795-19-4, Cevimeline CAS 107233-08-9 and ABT-869 CAS 796967-16-3.

Ang-2 inhibitors belong to a specific chemical class of compounds that target and inhibit the action of Angiopoietin-2 (Ang-2). Ang-2 is a naturally occurring protein that plays a critical role in regulating blood vessel formation and maturation, a process known as angiogenesis. It functions as a key modulator of vascular remodeling during various physiological and pathological conditions. Ang-2, along with other factors, mediates the dynamic balance between vessel stabilization and vessel destabilization. By binding to specific receptors on endothelial cells, Ang-2 promotes vessel destabilization and leakage, contributing to the formation of new blood vessels.

Ang-2 inhibitors work by interfering with the interaction between Ang-2 and its receptors on endothelial cells. By doing so, they modulate the angiogenesis process and impact the formation and maturation of blood vessels. These inhibitors have garnered significant attention in the scientific community due to their role in influencing angiogenesis-related processes in diverse contexts, such as wound healing, tissue regeneration, and various diseases like cancer and inflammatory disorders. Research into Ang-2 inhibitors is ongoing to elucidate their mechanisms of action and further understand their implications in different physiological and pathological conditions. The study of Ang-2 inhibitors represents a captivating area of research with promising avenues for future investigations in the field of biomedical science.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY-333,531 Hydrochloride

169939-93-9sc-364215
sc-364215A
1 mg
5 mg
$94.00
$287.00
6
(2)

A tyrosine kinase inhibitor that blocks Ang-2-induced phosphorylation and activation of Tie2 receptor, thereby reducing angiogenesis.

TG101348

936091-26-8sc-364740
sc-364740A
5 mg
25 mg
$207.00
$515.00
6
(1)

Selective inhibitor of Ang-2/Tie2 interaction, preventing angiogenic signaling and blood vessel destabilization.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Multitargeted kinase inhibitor that blocks receptors involved in angiogenesis, including Ang-2, suppressing tumor blood supply.

Cevimeline

107233-08-9sc-353133
25 mg
$1800.00
(0)

Inhibits Ang-2 expression by modulating M3 muscarinic receptor, reducing angiogenic responses.

ABT-869

796967-16-3sc-359037
sc-359037A
1 mg
5 mg
$126.00
$582.00
(0)

Multitargeted receptor tyrosine kinase inhibitor, suppressing both VEGF and Ang-2-mediated angiogenesis.

LY2157299

700874-72-2sc-391123
sc-391123A
5 mg
10 mg
$213.00
$359.00
3
(1)

TGF-beta receptor inhibitor, indirectly affecting Ang-2 expression and angiogenesis.

DCC-2036

1020172-07-9sc-364482
sc-364482A
10 mg
50 mg
$480.00
$1455.00
(0)

Dual inhibitor of Tie2 and VEGFR2, reducing angiogenesis and blood vessel destabilization.